Statistics for United Therapeutics (id:7230 UTHR)

Valuation metrics

Market cap

16.40B

Enterprise value

13.34B

Trailing P/E (ttm)

16.13

Forward P/E

13.18

PEG ratio

13.18

Price/Sales (ttm)

5.95

Price/Book (mrq)

2.69

Enterprise Value/Revenue

4.84

Enterprise Value/EBITDA

9.45

Overview

Shares outstanding

44.64M

Float

40.93M

Shares short

2.30M

% Held by insiders

0.02%

% Held by institutions

1.01%

Average volume (10 days)

351.06K

Average volume (90 days)

Price summary

52-Week low

208.62

52-Week high

417.82

52-Week change

38.01%

Beta

0.56

50-Day moving average

363.86

200-Day moving average

300.92

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

September 23th, 2009

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

40.30%

Operating margin

54.51%

Operational effectiveness

Return on assets

11.89%

Return on equity

18.81%

Income statement

Revenue (ttm)

60.24

Revenue per share (ttm)

60.24

Quarterly revenue growth (yoy)

0.16

Gross profit (ttm)

2.07B

EBITDA

1.62B

Net income to common (ttm)

1.11B

Diluted EPS (ttm)

22.77

Quarterly earnings growth (yoy)

15.50%

Balance sheet

Total cash (mrq)

3.33B

Total cash per share (mrq)

74.51

Total debt (mrq)

400.00M

Total Debt/Equity (mrq)

6.56

Current ratio (mrq)

458.00%

Book value per share (mrq)

136.74

Cash flow

Cash flow statement

1.14B

Levered free cash flow (LFCF)

710.09M